58 Ophthalmic complications After two years of low-dose semaglutide 1 mg once weekly in people with type 2 diabetes, there was a 76% increased risk of worsening retinopathy compared with placebo, although the absolute event rate was low (3.0% with semaglutide vs 1.8% with placebo)
Assessing metabolic health beyond HbA1c: fasting insulin, triglycerides, lactate, zone 2, and more [23:30]
Mounjaro (tirzepatide) EPAR Product Information
Additionally, in a Phase II clinical trial targeting a population with Metabolism-Associated Steatohepatitis (MASLD), treatment with 2.4 mg of pemvidutide for 24 weeks resulted in a relative liver fat content reduction of up to 76% as opposed to the placebo group's 14%
This condition can lead to several other side effects and interfere with blood sugar levels and nutrient absorption
Rybelsus semaglutida Propecto